semaglutide
The arrival of generic semaglutide in Canada significantly improves the cost-effectiveness and affordability of recommended treatments for up to 2.1 million Canadians living with Type 2 diabetes who face a high risk of cardiovascular disease, according to a simulation study led…
Peak volume
1K+
First seen
2026-08-17
Last seen
2026-08-21
Days trending
2 / 5
Countries
4
Trending timeline
Latest related news (2026-08-21)
-
Generic semaglutide could reshape diabetes drug coverage in Canada — McGill University
-
Sandoz, Biolab join Brazil’s growing semaglutide market — Valor International
-